These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Are short boys disadvantaged as adults? Follow-up of 77 men with constitutional growth delay and (or) familial short stature]. Holl RW, Schröder H, Heinze E. Dtsch Med Wochenschr; 1991 Jun 14; 116(24):928-34. PubMed ID: 2044460 [Abstract] [Full Text] [Related]
45. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort. Sarafoglou K, Addo OY, Turcotte L, Otten N, Wickremasinghe A, Pittock S, Kyllo J, Lteif AN, Himes JH, Miller BS. J Pediatr; 2014 May 14; 164(5):1141-1146.e1. PubMed ID: 24560184 [Abstract] [Full Text] [Related]
49. Initial high dose hydrocortisone (HDC) treatment for 21-hydroxylase deficiency (21-OHD) does not affect linear growth during the first three years of life. Takasawa K, Ono M, Miyai K, Matsubara Y, Takizawa F, Onishi T, Kashimada K, Mizutani S. Endocr J; 2012 May 14; 59(11):1001-6. PubMed ID: 22785554 [Abstract] [Full Text] [Related]
50. Final height in congenital adrenal hyperplasia: the dilemma of hypercortisolism versus hyperandrogenism. Cordeiro GV, Silva IN, Goulart EM, Chagas AJ, Kater CE. Arq Bras Endocrinol Metabol; 2013 Mar 14; 57(2):126-31. PubMed ID: 23525290 [Abstract] [Full Text] [Related]
51. Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Dörr HG. Horm Res; 2007 Mar 14; 68 Suppl 5():93-9. PubMed ID: 18174719 [Abstract] [Full Text] [Related]
52. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. Charmandari E, Hindmarsh PC, Johnston A, Brook CG. J Clin Endocrinol Metab; 2001 Jun 14; 86(6):2701-8. PubMed ID: 11397874 [Abstract] [Full Text] [Related]
53. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China. Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D. J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598 [Abstract] [Full Text] [Related]
56. Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature. Crowe BJ, Rekers-Mombarg LT, Robling K, Wolka AM, Cutler GB, Wit JM, European Idiopathic Short Stature Group. J Clin Endocrinol Metab; 2006 Jan 01; 91(1):169-75. PubMed ID: 16263828 [Abstract] [Full Text] [Related]
57. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy. Zimmermann A, Sido PG, Schulze E, Al Khzouz C, Lazea C, Coldea C, Weber MM. Clin Endocrinol (Oxf); 2009 Oct 01; 71(4):477-84. PubMed ID: 19170706 [Abstract] [Full Text] [Related]
58. Growth in disorders of adrenal hyperfunction. Savage MO, Scommegna S, Carroll PV, Ho JT, Monson JP, Besser GM, Grossman AB. Horm Res; 2002 Oct 01; 58 Suppl 1():39-43. PubMed ID: 12373013 [Abstract] [Full Text] [Related]
59. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method. Bonfig W, Schwarz HP. J Pediatr Endocrinol Metab; 2012 Oct 01; 25(7-8):645-9. PubMed ID: 23155688 [Abstract] [Full Text] [Related]
60. Final height and pubertal development in children with growth hormone deficiency after long-term treatment. Frisch H, Birnbacher R. Horm Res; 1995 Oct 01; 43(4):132-4. PubMed ID: 7750913 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]